Csnk1E Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{infobox .infobox-protein}}
| Property |
Value |
| Protein Name |
Casein Kinase 1 Epsilon |
| Gene Symbol |
CSNK1E |
| UniProt ID |
P49674 |
| Molecular Weight |
~55 kDa |
| Subcellular Localization |
Cytoplasm, Nucleus, Cytoskeleton |
| Protein Family |
Casein Kinase 1 family |
| Enzyme Classification |
Serine/Threonine protein kinase |
CSNK1E (Casein Kinase 1 Epsilon) is a member of the casein kinase 1 (CK1) family of serine/threonine protein kinases. CK1 enzymes are highly conserved across eukaryotes and regulate numerous cellular processes including circadian rhythm, DNA repair, Wnt signaling, and membrane trafficking. CSNK1E is particularly important in the nervous system, where it modulates circadian rhythm, neuronal signaling, and protein aggregation pathways relevant to neurodegenerative diseases.
The CSNK1E protein contains several functional domains:
- N-terminal catalytic domain (1-300 aa): Contains the kinase active site with the conserved residues V71, D149, and E157 required for ATP binding and catalysis
- C-terminal regulatory domain (300-463 aa): Contains autophosphorylation sites and mediates protein-protein interactions
- Nuclear localization signal (NLS): Positions 75-92, facilitating nuclear import
The kinase adopts a typical bilobal structure with a smaller N-terminal lobe (β-strands) and larger C-terminal lobe (α-helices), similar to other protein kinases.
CSNK1E is a core component of the mammalian circadian clock:
- PER phosphorylation: Phosphorylates PERIOD (PER) proteins, targeting them for degradation
- CRY stabilization: Regulates cryptochrome protein stability
- Clock-BMAL1 cycle: Modulates the transcriptional-translational feedback loop
- Temperature compensation: Maintains circadian rhythm stability across temperature ranges
- Synaptic plasticity: Regulates AMPA receptor trafficking and function
- Dendritic spine morphology: Modifies actin cytoskeleton dynamics
- Ion channel regulation: Phosphorylates various ion channels
- Wnt signaling: Participates in β-catenin degradation complex
- DNA repair: Involved in nucleotide excision repair
- Apoptosis: Regulates p53 and caspase activation
CSNK1E contributes to AD pathogenesis through multiple mechanisms:
- Tau hyperphosphorylation: Phosphorylates tau at multiple sites (Ser199, Ser202, Thr205), promoting NFT formation
- Amyloid processing: Modulates APP processing and Aβ generation
- Circadian disruption: CK1ε dysfunction contributes to sleep-wake cycle abnormalities in AD
- Synaptic dysfunction: Alters synaptic protein phosphorylation
- Alpha-synuclein phosphorylation: Phosphorylates α-syn at Ser129, influencing aggregation
- Circadian dysfunction: Altered CK1ε activity contributes to sleep disorders in PD
- Dopaminergic signaling: Modulates dopamine receptor function
- TDP-43 phosphorylation: May phosphorylate TDP-43 aggregates
- Circadian disruption: Sleep disturbances in ALS patients
- Mutant huntingtin phosphorylation: CK1ε may phosphorylate huntingtin
- Transcriptional dysregulation: Affects clock gene expression
Several CK1 inhibitors are being developed:
- PF-670462: CK1δ/ε inhibitor, in preclinical testing for AD
- IC261: CK1δ/ε inhibitor, shows neuroprotective effects
- CX-4945: CK2 inhibitor with some CK1 activity
- Isoform specificity: Achieving selectivity between CK1δ and CK1ε
- Blood-brain barrier penetration: Essential for CNS targeting
- Peripheral effects: CK1 has widespread functions
| Partner |
Interaction Type |
Function |
| PER1 |
Substrate |
Circadian regulation |
| PER2 |
Substrate |
Circadian regulation |
| CRY1 |
Substrate |
Circadian regulation |
| BMAL1 |
Partner |
Transcription factor |
| Tau (MAPT) |
Substrate |
Phosphorylation |
| α-Synuclein |
Substrate |
Ser129 phosphorylation |
The study of Csnk1E Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Casein kinase 1 epsilon: another isoform with neuronal importance (2014)
- Therapeutic potential of CK1 inhibitors for neurodegenerative diseases (2020)
- CK1ε and tau phosphorylation in Alzheimer's disease (2018)
- Alpha-synuclein phosphorylation by CK1ε (2019)
- Circadian clock and neurodegeneration (2020)
- CK1 inhibitors for AD treatment (2021)
- Casein kinase 1 in synaptic plasticity (2017)
- Wnt signaling and CK1 (2016)